Manappuram Finance shares witnessed an uptick on Wednesday after Q1 FY27 profit surged nearly four-fold to Rs 585 crore. Jefferies raised its target price to Rs 430, citing better NII and lower provisions, while Morgan Stanley also raised its target. CLSA retained a Hold rating, with a Rs 350 target price.
Dr Agarwals Health shares fall 7% after Rs 2,065-crore block deal; Hyperion Investments, Claymore likely sellers
Dr Agarwals Health Care shares dropped on Wednesday after a Rs 2,065-crore block deal involving 4.07 crore shares. Hyperion Investments and Claymore Investments were likely